-+ 0.00%
-+ 0.00%
-+ 0.00%

EDGEWISE THERAPEUTICS DOSES FIRST PATIENT IN PHASE 2 EQUINOX-HFPEF TRIAL OF EDG-15400

Reuters·10/08/2026 12:00:07

Please log in to view news